Related Experiment Video
Updated: Jun 11, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Release of prostaglandin E(2) and nitric oxide from spinal microglia is dependent on activation of p38
Tomohiro Matsui1, Camilla I Svensson, Yuka Hirata
1Department of Laboratory Sciences, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Background:
The spinal release of prostaglandins (PGs), nitric oxide (NO), and cytokines has been implicated in spinal nociceptive processing. Microglia represent a possible cell of origin for these proexcitatory mediators. Spinal microglia possess Toll-like receptor 4 (TLR4) and neurokinin 1 (NK1) receptors, and both receptors play a significant role in peripheral nerve injury- and inflammation-induced spinal sensitization. Accordingly, we examined the properties of the cascades activated by the respective targets, which led to the release of PGE(2) and an increase in nitrite (NO(2)(-)) (a marker of NO) from cultured rat spinal microglia.
Methods:
Spinal microglia isolated from Sprague-Dawley neonatal rats were cultured with lipopolysaccharide (LPS) or substance P (SP) alone, with LPS in combination with SP, and with LPS in the presence of each inhibitor of cyclooxygenase (COX), NO synthase 2 (NOS2) or p38 mitogen-activated protein kinase (p38), or minocycline for 24 hours and 48 hours. Concentrations of PGE(2) and NO(2)(-) in culture supernatants were measured using an enzyme immunoassay and a colorimetric assay, respectively.
Results:
Application of LPS (a TLR4 ligand, 0.1 to 10 ng/mL) to cultured microglia produced a dose- and time-dependent increase in PGE(2) and NO(2)(-) production, whereas no effects were observed after incubation with SP (an NK1 agonist, up to 10(-5) M) alone or in combination with LPS. Antagonist studies with SC-560 (COX-1 inhibitor) and SC-236 (COX-2 inhibitor) showed that LPS-induced PGE(2) release was generated from both COX-1 and COX-2. LPS-induced NO release was suppressed by 1400W, an inhibitor of NOS2. Minocycline, an agent blocking microglial activation, and SB203580, an inhibitor of p38, both attenuated the LPS-induced PGE(2) and NO release. The 1400W, at the doses that suppressed NO release, also blocked increased PGE(2) release.
Conclusions:
Our findings suggest that (a) activation of spinal microglia via TLR4 but not NK1 receptors produces PGE(2) and NO release from these cells; (b) the evoked PGE(2) release is generated by both COX-1 and COX-2, and (c) the COX-PGE(2) pathway is regulated by p38 and NOS2. Taken together with our previous in vivo work, the current findings emphasize that p38 in spinal microglia is a key player in regulating production of pronociceptive molecules, such as PGE(2) and NO.
Insights
Spinal microglia activation via Toll-like receptor 4 (TLR4) releases prostaglandin E2 (PGE2) and nitric oxide (NO). This release is regulated by p38 and NO synthase 2 (NOS2), highlighting p38's role in pain signaling.
Area of Science:
- Neuroscience
- Immunology
- Pain Research
Background:
- Spinal prostaglandins (PGs), nitric oxide (NO), and cytokines are involved in pain processing.
- Microglia, the immune cells of the central nervous system, are potential sources of these pain-mediating substances.
- Spinal microglia express Toll-like receptor 4 (TLR4) and neurokinin 1 (NK1) receptors, implicated in spinal sensitization following nerve injury or inflammation.
Purpose of the Study:
- To investigate the signaling pathways in cultured rat spinal microglia activated by TLR4 and NK1 receptors.
- To determine the production of prostaglandin E2 (PGE2) and nitric oxide (NO) in response to these activations.
- To elucidate the roles of cyclooxygenase (COX), NO synthase 2 (NOS2), and p38 mitogen-activated protein kinase (p38) in these responses.
Main Methods:
- Primary cultures of rat spinal microglia were treated with lipopolysaccharide (LPS, a TLR4 ligand) and/or substance P (SP, an NK1 agonist).
- Inhibitors of COX (SC-560, SC-236), NOS2 (1400W), p38 (SB203580), and minocycline were used to block specific pathways.
- PGE2 and nitrite (NO marker) concentrations in culture supernatants were measured via enzyme immunoassay and colorimetric assay.
Main Results:
- LPS stimulation dose-dependently increased PGE2 and NO2- production, while SP had no effect alone or with LPS.
- LPS-induced PGE2 release involved both COX-1 and COX-2.
- LPS-induced NO release was inhibited by 1400W (NOS2 inhibitor).
- Minocycline and the p38 inhibitor SB203580 attenuated both LPS-induced PGE2 and NO release.
- Inhibition of NOS2 also blocked the increased PGE2 release, suggesting cross-talk between pathways.
Conclusions:
- Activation of spinal microglia via TLR4, not NK1, triggers the release of PGE2 and NO.
- Both COX-1 and COX-2 contribute to LPS-induced PGE2 production.
- The COX-PGE2 pathway is modulated by p38 and NOS2.
- p38 in spinal microglia is a critical regulator of pronociceptive molecule production (PGE2, NO), reinforcing its role in pain signaling.
Related Concept Videos
Nitric Oxide Signaling Pathway
IP3/DAG Signaling Pathway
MAPK Signaling Cascades
GPCRs Regulate Adenylyl Cylase Activity
Two...
Amplifying Signals via Second Messengers
Amplifying Signals via Enzymatic Cascade